Delivery Order HHSN261201000016I-HHSN26100001
Award Date 4/6/10
Potential Completion Date 9/30/14
Potential Value $49K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
West Hollywood, CA 90048, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Cedars-Sinai Medical Center, a nonprofit hospital and academic medical center located in Los Angeles. The contract, valued at $20,636.55, is part of the NCI Cancer Genome Atlas Program and supports the collection of tissue samples and data from various types of cancer for the program. The contract does not have a set-aside designation. Cedars-Sinai Medical Center is an...
- This is a federal contract award from the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Cedars-Sinai Medical Center. The $21,934 firm-fixed-price contract was awarded on July 14, 2010 under the NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery vehicle. The contract supports the collection of tissue samples and data from various cancer types for the Cancer Genome Atlas (TCGA) program, which aims to comprehensively characterize...
- This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to the Sloan-Kettering Institute for Cancer Research, a non-profit organization, under the NCI Cancer Genome Atlas Program Tissue Purchase contract vehicle. The $120,500 award provides for the collection and supply of tissue samples and data from various cancer types to support the Cancer Genome Atlas (TCGA) program, which is focused on comprehensive genomic characterization of cancers. This award is...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract supports the NCI's Cancer Genome Atlas (TCGA) program, which aims to collect and analyze tissue samples and data from various cancer types. The total ceiling value of the contract is $42,000.00. This contract is part of the NCI's Cancer Genome Atlas Program Tissue Purchase master IDIQ contract. The contract...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) in the amount of $201,998.50. The contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase, an indefinite delivery contract. The contract is for the recovery and provision of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is part of the...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), which is part of the Department of Health and Human Services (HHS), to Yale University. The contract is to support the Cancer Genome Atlas (TCGA) program by providing tissue samples and data from various types of cancer, as part of the American Recovery and Reinvestment Act (ARRA). The contract has a ceiling value of $76,875 and a period of performance ending on March 31, 2015. This contract was...
- This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to the Sloan-Kettering Institute for Cancer Research, a non-profit organization focused on cancer research and patient care. The $178,230.00 award is part of the NCI Cancer Genome Atlas Program and supports the recovery of tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program, which is funded through the American Recovery and Reinvestment Act (ARRA). The contract has...
- This federal contract award was issued by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the Sloan-Kettering Institute for Cancer Research, a non-profit organization focused on cancer research and patient care. The $211,000.00 firm fixed-price contract is a delivery order under the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ contract. The contract is for the provision of tissue samples and data from various types of cancer for...
- This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian federal agency, to Ilsbio LLC, a for-profit limited liability company. The contract is for the recovery of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. This award is part of the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ contract and is funded under the American Recovery and Reinvestment Act (ARRA). The contract has a...
- This is a firm-fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Indivumed, Inc. for the Cancer Genome Atlas (TCGA) program. The $1,337,077.50 contract is to provide tissue samples and data from various types of cancer for the TCGA program, which aims to characterize the genomic changes involved in cancer. The award is not associated with a set-aside program. This delivery order is part of...
- HHSN261201000016IIndefinite Delivery Contract
- HHSN261201000016I-HHSN26100001Delivery Order
This is a firm fixed-price delivery order awarded by the National Cancer Institute to Cedars-Sinai Medical Center, a nonprofit hospital and academic medical center in Los Angeles, under the NCI Cancer Genome Atlas Program Tissue Purchase contract vehicle. The $48,999.75 award is for providing tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is funded through the American Recovery and Reinvestment Act (ARRA). The work is to be completed by September 30, 2014. Cedars-Sinai has a history of providing biomedical research, healthcare services, and preparedness efforts to federal agencies through prime and subcontracts. This award does not have a set-aside designation.
Generated 4/3/25, 11:18 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
RECOVERY: Tissue Purchase Order Contract Acquisition for NCI's The Cancer Genome Atlas Program | RFQ-NCI-10007-AS | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 12/4/09, 8:15 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 4 | Other Administrative Action | $0 | 5/20/15 | |
| 3 | Funding Only Action | $2.6k | 3/24/15 | |
| 2 | Other Administrative Action | $0 | 11/7/11 | |
| 1 | Funding Only Action | $32.1k | 9/21/10 | |
| Not listed | Not listed | $14.3k | 4/6/10 |